Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only: clinical study

Share/Save/Bookmark

Jobsen, Jan J. and Naudin ten Cate, Lambert and Lybeert, Marnix L.M. and Scholten, Astrid and Steen-Banasik van der, Elzbieta M. and Palen van der, Job and Stenfert Kroese, Marika C. and Slot, Annerie and Schutter, Eltjo M. and Siesling, Sabine (2011) Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only: clinical study. Obstetrics and Gynecology International, 2011 . p. 962518. ISSN 1687-9589

[img]
Preview
PDF
682Kb
Abstract:Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa
Item Type:Article
Copyright:© 2011 The Author(s)
Faculty:
Management and Governance (SMG)
Research Group:
Link to this item:http://purl.utwente.nl/publications/77985
Official URL:http://dx.doi.org/10.1155/2011/962518
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page

Metis ID: 282243